Pharmacokinetics, Safety and Tolerability of Single and Multiple Oral Doses of Aliskiren in Healthy Chinese Subjects: A Randomized, Single-Blind, Parallel-Group, Placebo-Controlled Study

By Hu Pei  

Clinical Drug Investigation, Vol. 30, Iss. 4, 2010-04 ,pp. : 221-228

Adis International

Access to resources Recommend Favorite

Safety, Tolerability and Pharmacokinetics of Dalcetrapib Following Single and Multiple Ascending Doses in Healthy Subjects: A Randomized, Double-Blind, Placebo-Controlled, Phase I Study

By Derks Michael   Anzures-Cabrera Judith   Turnbull Lynn   Phelan Mary  

Clinical Drug Investigation, Vol. 31, Iss. 5, 2011-05 ,pp. : 325-335

Adis International

Access to resources Recommend Favorite

A Phase 1 Randomized, Placebo‐Controlled Study Assessing the Pharmacokinetics, Safety, and Tolerability of Retosiban in Healthy, Nonpregnant Japanese Subjects

By  

Clinical Pharmacology In Drug Development, Vol. 7, Iss. 1, 2018-01 ,pp. : 59-66

John Wiley & Sons Inc

Access to resources Recommend Favorite

Safety, Tolerability and Pharmacokinetics of Sugammadex Using Single High Doses (Up to 96 mg/kg) in Healthy Adult Subjects: A Randomized, Double-Blind, Crossover, Placebo-Controlled, Single-Centre Study

By Peeters Pierre A.M.  

Clinical Drug Investigation, Vol. 30, Iss. 12, 2010-12 ,pp. : 867-874

Adis International

Access to resources Recommend Favorite

Pharmacokinetics, Safety, and Tolerability of GLPG0259, a Mitogen-Activated Protein Kinase-Activated Protein Kinase 5 (MAPKAPK5) Inhibitor, Given as Single and Multiple Doses to Healthy Male Subjects

By Namour Florence  

Drugs in R&D, Vol. 12, Iss. 3, 2012-09 ,pp. : 141-163

Adis International

Access to resources Recommend Favorite